Skip to main content
. 2016 Jan 10;40(3):194–200. doi: 10.1093/jat/bkv143

Table I.

Tandem mass spectrometric conditions

Compound Precursor ion (m/z) Target/qualifier ions (m/z) DP (V) FP (V) EP (V) CE (V) CXP (V)
2C-B 260.0 243.0
228.0
15 300 4.0 18
30
10
4.6
2C-I 308.1 291.1
276.1
15 300 5.0 21
35
6.5
5.4
2C-T-2 242.2 225.2
134.2
15 200 5.0 19
37
4.8
5.0
2C-T-7 256.2 239.2
197.2
15 300 5.0 19
30
5.4
8.0
DMA 196.2 151.2
179.2
15 200 8.0 16
24
3.2
6.0
DOB 274.0 257.0
229.0
15 300 5.0 22
33
5.9
4.3
DOET 224.2 207.2
179.2
11 300 4.0 20
27
4.7
7.4
DOM 210.2 193.2
178.2
10 200 6.0 18
27
4.3
3.5
MDE 209.1 164.1
78.1
21 200 7.0 19
63
10
12
MDMA 194.2 163.2
105.2
21 200 7.0 12
35
8
18
PMA 166.1 149.1
121.1
10 200 6.0 13
27
2.2
2.0
PMMA 180.1 121.1
149.1
15 200 6.0 18
25
2.2
4.6
TMA 226.2 209.2
181.2
15 200 4.0 16
29
4.6
3.0
IS 185.0 168.0 15 200 8.0 20 7

DP, declustering potential; FP, focusing potential; EP, entrance potential; CE, collision energy; CXP, collision cell exit potential; 2C-B, 2,5-dimethoxy-4-bromophenethylamine; 2C-I, 2,5-dimethoxy-4-iodophenethylamine; 2C-T-2, 2,5-dimethoxy-4-ethylthiophenethylamine; 2C-T-7, 2,5-dimethoxy-4-n-propylthiophenethylamine; DMA, 2,5-dimethoxyamphetamine; DOB, 2,5-dimethoxy-4-bromoamphetamine; DOET, 2,5-dimethoxy-4-ethylamphetamine; DOM, 2,5-dimethoxy-4-methylamphetamine; MDE, 3,4-methylenedioxy-N-ethylamphetamine; MDMA, 3,4-methylenedioxy-N-methylamphetamine; PMA, p-methoxyamphetamine; PMMA, p-methoxymethamphetamine; TMA, 3,4,5-trimethoxyamphetamine; IS, 2,3-dimethoxyphenethylamine-d3.